Clin2
NCT07514416Likely a fitRecruiting

Safety study of LCFA-01 drug in healthy women

Bacterial Vaginosis Treatment

Part of Infections, Women’s health & pregnancy clinical trials.

This study tests a new drug called LCFA-01 to make sure it's safe and works as expected in healthy women. The drug is being developed to treat bacterial vaginosis, a common vaginal infection.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
30 people
Ages
18 years to 40 years
Study type
Interventional

Who can take part

  • You are a woman aged 18–40 and not yet going through menopause
  • You are generally healthy with normal blood and urine test results
  • Your weight and height are in a healthy range (BMI 18.0–34.9)
  • You do not smoke, or smoke 2 cigarettes or less per week
  • You test negative for sexually transmitted infections and hepatitis/HIV
  • You are willing to avoid vaginal products, sexual activity, and use reliable birth control during the study

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07302035Not yet recruiting· Phase 1
Safety study of a single vaginal dose in healthy women

This trial tests a single dose of an investigational drug given vaginally to healthy Chinese women. It aims to see if the drug is safe and how the body processes it.

Shanghai, Shanghai Municipality
NCT06821789Not yet recruiting
Probiotic study for bacterial vaginosis in women

This trial tests if a probiotic called LRa05 can help treat bacterial vaginosis (an imbalance in vaginal bacteria) and support ovary health. It may be an option for premenopausal women with this condition.

NCT07481955Recruiting· Phase 2
A study of chlorhexidine and metronidazole plus FB301 for bacterial vaginosis

This trial tests a pre-treatment with chlorhexidine and/or metronidazole before a new drug called FB301 in women with bacterial vaginosis (BV). It aims to see if this combination is safe and works well.

Berlin, State of Berlin
NCT05434104Recruiting
Trial tests vaginal lactoferrin instead of medicines for BV or thrush

This study checks whether using lactoferrin vaginal pessaries can work for bacterial vaginosis (BV) or thrush, compared with standard antibiotic or antifungal tablets. It’s a feasibility study, meaning the main goal is to see if the approach and home sample collection are practical.

London
NCT06450990Not yet recruiting· Phase 1/Phase 2
Testing a probiotic for vaginal infections

This trial tests a new live biotherapeutic product (a kind of probiotic) to treat bacterial vaginosis or yeast infections. It compares different doses to see which works best and is safest for relieving symptoms.

NCT07181486Recruiting· Phase 1
Safety study of a vaginal gel for healthy women

This trial tests a gel placed in the vagina to see if it is safe. Healthy women with regular periods who have a steady partner may join.

San Francisco, California

Hear when a new Bacterial Vaginosis Treatment trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.